Literature DB >> 22546829

Association between OPG, RANK and RANKL gene polymorphisms and susceptibility to acute coronary syndrome in Korean population.

Won-Seok Choe1, Hack-Lyoung Kim, Jung-Kyu Han, Young-Eun Choi, Borami Seo, Hyun-Jai Cho, Han-Kwang Yang, Kyu-Joo Park, Jin-Shik Park, Hun-Jun Park, Pum-Joon Kim, Sang-Hong Baek, Ki-Bae Seung, Hyo-Soo Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22546829     DOI： 10.1007/s12041-012-0131-0

Source DB:  PubMed          Journal:  J Genet        ISSN： 0022-1333            Impact factor:   1.166


× No keyword cloud information.
  18 in total

1.  Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction.

Authors:  Dong-Hai Xiong; Hui Shen; Lan-Juan Zhao; Peng Xiao; Tie-Lin Yang; Yan Guo; Wei Wang; Yan-Fang Guo; Yong-Jun Liu; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-11       Impact factor: 6.741

Review 2.  Minireview: the OPG/RANKL/RANK system.

Authors:  S Khosla
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

3.  Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques.

Authors:  C R Dhore; J P Cleutjens; E Lutgens; K B Cleutjens; P P Geusens; P J Kitslaar; J H Tordoir; H M Spronk; C Vermeer; M J Daemen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-12       Impact factor: 8.311

4.  Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization.

Authors:  Wiggo J Sandberg; Arne Yndestad; Erik Øie; Camilla Smith; Thor Ueland; Olga Ovchinnikova; Anna-Karin L Robertson; Fredrik Müller; Anne G Semb; Hanne Scholz; Arne K Andreassen; Lars Gullestad; Jan Kristian Damås; Stig S Frøland; Göran K Hansson; Bente Halvorsen; Pål Aukrust
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-01-19       Impact factor: 8.311

5.  Osteoprotegerin gene polymorphisms in men with coronary artery disease.

Authors:  Muhidien Soufi; Michael Schoppet; Alexander M Sattler; Matthias Herzum; Bernhard Maisch; Lorenz C Hofbauer; Juergen R Schaefer
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

6.  Multiple genetic loci for bone mineral density and fractures.

Authors:  Unnur Styrkarsdottir; Bjarni V Halldorsson; Solveig Gretarsdottir; Daniel F Gudbjartsson; G Bragi Walters; Thorvaldur Ingvarsson; Thorbjorg Jonsdottir; Jona Saemundsdottir; Jacqueline R Center; Tuan V Nguyen; Yu Bagger; Jeffrey R Gulcher; John A Eisman; Claus Christiansen; Gunnar Sigurdsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  N Engl J Med       Date:  2008-04-29       Impact factor: 91.245

7.  Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.

Authors:  Jung Gu Kim; Jung Hwa Kim; Ja Yeon Kim; Seung Yup Ku; Byung Chul Jee; Chang Suk Suh; Seok Hyun Kim; Young Min Choi
Journal:  Menopause       Date:  2007 Sep-Oct       Impact factor: 2.953

8.  Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis.

Authors:  Simona Mencej; Omar M E Albagha; Janez Prezelj; Tomaz Kocjan; Janja Marc
Journal:  J Mol Endocrinol       Date:  2008-06       Impact factor: 5.098

9.  Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease.

Authors:  Stefan Kiechl; Georg Schett; Judith Schwaiger; Klaus Seppi; Paula Eder; Georg Egger; Peter Santer; Agnes Mayr; Qingbo Xu; Johann Willeit
Journal:  Circulation       Date:  2007-07-09       Impact factor: 29.690

Review 10.  Functions of RANKL/RANK/OPG in bone modeling and remodeling.

Authors:  Brendan F Boyce; Lianping Xing
Journal:  Arch Biochem Biophys       Date:  2008-03-25       Impact factor: 4.013
View more
  6 in total

1.  Association of gene polymorphisms in RANKL/RANK/OPG system with hypertension and blood pressure in Chinese women.

Authors:  P Duan; Z-M Wang; J Liu; L-N Wang; Z Yang; P Tu
Journal:  J Hum Hypertens       Date:  2015-03-26       Impact factor: 3.012

2.  Hsa-mir-499 rs3746444 T/C Polymorphism is Associated with Increased Risk of Coronary Artery Disease in a Chinese Population.

Authors:  Weiqiang Chen; Donghua Shao; Haiyong Gu; Jie Gong; Jian Zhang
Journal:  Acta Cardiol Sin       Date:  2017-01       Impact factor: 2.672

Review 3.  Influence of single nucleotide polymorphisms (SNPs) in genetic susceptibility towards periprosthetic osteolysis.

Authors:  Supriya Jagga; Ashish Ranjan Sharma; Manojit Bhattacharya; Chiranjib Chakraborty; Sang-Soo Lee
Journal:  Genes Genomics       Date:  2019-07-16       Impact factor: 1.839

4.  Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients.

Authors:  Anna Shen; Xuwei Hou; Deguang Yang; Tingrong Liu; Dezhong Zheng; Liehua Deng; Tao Zhou
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

5.  Evaluation of rs3102735 and rs2073617 Osteoprotegerin Gene Polymorphisms and the Risk of Childhood Acute lymphoblastic Leukemia in Zahedan Southeast Iran.

Authors:  Mohammad Hashemi; Mahboubeh Ebrahimi; Shadi Amininia; Majid Naderi; Ebrahim Eskandari-Nasab; Mohsen Taheri
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014-10-01

Review 6.  Pathophysiological and Genetic Aspects of Vascular Calcification.

Authors:  Luis Fernando Escobar Guzman; Cristian Andres Escobar Guzman; Neuza Helena Moreira Lopes
Journal:  Cardiol Res Pract       Date:  2020-04-14       Impact factor: 1.866
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.